Scienture Holdings, Inc. - 8-K Filing
Scienture Holdings, Inc. reported Q1 2026 revenue of $56 thousand, a 449% increase from $10 thousand in Q1 2025, driven by incremental product orders for ArbliTM following its commercial launch. Gross profit rose to $54 thousand (a 7900% YoY increase) with gross margin expanding to 95.6%. The company secured $11 million in non-dilutive debt financing and received a third patent for ArbliTM, extending market exclusivity through 2041. (Items: 2.02 Results of Operations and Financial Condition, 9.01 Financial Statements and Exhibits)
Tickers: $MEDS